02 avril 2007, 0h00
Partager
KKR has added a spoonful of sugar to its bid for Alliance Boots. The private equity group has raised its price for the UK healthcare group to £10.40 a share, giving an enterprise value of £11.4bn. That has secured the due diligence KKR wanted, and is probably enough to wring a recommendation from the board. True, the price isn’t a knock-out. But it is a respectable 30% premium to Boots’ average share price in the six months before KKR revealed its hand. At 13 times ebitda for the current financi...
Ce contenu est LIBRE d’accès. Pour le lire, il vous suffit de créer un COMPTE GRATUIT